pancreatic cancer

Patient Johnny Cleveland, right, with Kamran Idrees, MD, MSCI, MMHC.
May 29, 2024

Robotic pancreatectomy speeds recovery time for retired educator 

He knew he needed complicated surgery, so researching his options, he learned about the Vanderbilt surgical team led by Kamran Idrees, MD, MSCI, MMHC, Ingram Associate Professor of Cancer Research.

By Tom Wilemon
February 16, 2023

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.

By Tom Wilemon
(iStock)
September 29, 2022

Vanderbilt lauded for pancreatic cancer, pancreatitis care

Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

By Tom Wilemon
September 22, 2022

Nerve cells and cancer progression

Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

By Leigh MacMillan
(iStock)
August 12, 2019

Pancreatic cancer clue

Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

By Niyati Vachharajani
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

By Leigh MacMillan
December 7, 2017

Searching out pancreatic cancer risk

Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.
By Paul Govern
August 31, 2017

Pancreatic cancer development

Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.
By Leigh MacMillan
January 19, 2017

Metastatic pancreatic cancer ‘reprograms’ for malignancy

Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics.
By Leigh MacMillan
February 25, 2016

Chemo better option following pancreatic cancer surgery: study

A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.
By VUMC News and Communications
January 29, 2015

Grant bolsters pancreatic cancer drug discovery efforts

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.
By VUMC News and Communications
January 9, 2014

Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.
By Bill Snyder
January 17, 2013

Study helps define pancreatic cancer’s cellular origins

Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments.
By Leigh MacMillan
1 2